We have previously reported the expression of CYP genes in human myeloblastic and lymphoid cell lines, and the induction of the CYP3A4 and GSTP1 genes by oxidative stress in the human erythroleukemia cell line, K562. To further elucidate the role of drug metabolizing enzymes in hematogenesis, we have characterized the expression of CYP genes in hemin-induced differentiated K562 cells. After incubation with 50 m mM hemin for 3 d, the expression of CYP1A1 and CYP3A4 genes was induced by 2.5-and 3.5-fold, respectively. In contrast, the CYP1B1 and CYP2E1 genes were downregulated in these cells to below 10% of the control levels. Moreover, these changes correlated with the hemin dose and culture time. Metabolism of midazolam, a probe substrate for CYP3A4, in the differentiated K562 cells increased by 2-folds, suggesting that the induction of CYP3A4 activity is consistent with the mRNA level. If these changes in the CYP expression profile in hematopoietic cells occurred, the susceptibility to xenobiotics and/or the therapeutic drugs of the cells might be influenced, and it also affects the metabolism of endogenous substrates, such as steroids and prostaglandins.
The metabolism of foreign compounds in the body into polar, hydrophilic compounds is an important prerequisite for the detoxification and eventual elimination of xenobiotics from the body. This mechanism also provides the first line of intracellular defense and is mediated by a number of enzyme superfamilies, including cytochrome P450 (CYP) and several conjugation enzymes including the sulfotransferases, UDPglucuronosyl transferases and glutathione S-transferases. These enzymes also catalyze the bioactivation and inactivation of a wide variety of endogenous compounds, including steroid hormones and eicosanoids. Most of these enzymes are localized in the liver but many are also expressed in extrahepatic tissues such as the small intestine, the lungs and the kidneys. [1] [2] [3] Among the extrahepatic tissues, little is known about the expression of drug metabolizing enzymes in peripheral blood cells. CYP1A1 enzymes in human peripheral blood lymphocytes might be responsible for aryl hydrocarbon hydroxylation, which is reported to correlate positively with the susceptibility to lung cancer from tobacco smoke exposure. 4) It has also been reported that CYP3A enzymes are expressed in human polymorphic neutrophiles (PMNs). 5, 6) Previously, we have reported that CYP genes are expressed in the human myeloblastic and lymphoid cell lines, 7) and reported the induction of the CYP3A4 and GSTP1 genes by oxidative stress in the human erythroleukemia cell line, K562. 8) However, only limited data is currently available concerning the lineage specific expression of drug metabolizing enzymes and a more detailed understanding of this will potentially clarify the role of these enzymes during hematogenesis and in the etiology of human hematopoietic malignancy and bone marrow chemotherapeutic drug resistance. The human leukemia K562 cell line is a well-established model system for the study of both spontaneous and induced differentiation to erythrocytic, granulocytic and monocytic lineages. K562 cells are precursors that proceed toward erythroid differentiation upon treatment with agents such as hemin. When induced to differentiate with hemin, K562 cells produce the embryonic and fetal hemoglobin, a property associated with the more mature erythroid cells. Our present study describes the changes in the expression of CYP genes in differentiated K562 cells induced by hemin.
MATERIALS AND METHODS

Materials
Reagents for cDNA synthesis were purchased from Stratagene (California, U.S.A.). Taq DNA polymerase was purchased from Perkin-Elmer (California, U.S.A.). Media and supplements for cell culture were purchased from GIBCO BRL (New York, U.S.A.). Other reagents were obtained from Wako Pure Chemicals (Tokyo, Japan). The human erythroleukemia cell line, K562, was purchased from RIKEN Cell Bank (Wako, Saitima, Japan).
Cells and Cell Culture K562 cells (2ϫ10 5 cells/ml) were cultured in suspension in RPMI1640 medium (Life Technologies, Inc., Gaithersburg, MD, U.S.A.) supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere of 5% CO 2 in air.
Induction of Cell Differentiation The differentiation of K562 cells towards the erythroid lineage was induced by the addition of hemin at final concentrations of 15, 30 and 50 mM. This process was monitored by the benzidine staining method as previously described.
9)
RNA Isolation and Reverse Transcription-PCR (RT-PCR) Total RNA was isolated from cultured cells by guanidium thiocyanate phenol-chloroform extraction. 10) First strand cDNAs were synthesized from 10 mg of total RNA by 1 unit M-MLV reverse transcriptase with oligo(dT) primers, according to the manufacturer's protocol. PCR was carried out using these cDNAs as a template with AmpliTaq Gold polymerase (Perkin-Elmer). The primers used to amplify human CYPs, arnt and AhR cDNAs are as described, 8) and those of nuclear receptors cDNAs (CAR, PXR and VDR) were adopted from the published sequences. [11] [12] [13] The sequences are as follows: CAR, forward 5Ј-AA-GGAGCAAGAAGAGCTGATC-3Ј and reverse 5Ј-TCAG-CTGCAGATTCTCCTGGAG-3Ј; PXR, forward 5Ј-GCAG-GAGCAATTCGCCATT-3Ј and reverse 5Ј-TCGGTGAG-CATAGCCATGATCC-3Ј; VDR, forward 5Ј-GACTTTGAC-CGGAACGTGCC-3Ј and reverse 5Ј-CATCATGCCGAT-GTCCACAC-3Ј. Cycling conditions (30-40 cycles) were as follows: 1 min at 94°C, 1.5 min at 54-58°C and 2 min at 72°C.
Quantitative PCR Quantitative real-time PCR was performed in an ABI-Prism 7700 thermal cycler using a SYBR green PCR core reagent kit (Applied Biosystems, Wharmington, U.K.). Samples were denatured at 94°C for 10 min, and cDNA products were amplified with 40 cycles of 94°C for 30 s and 60°C for 60 s. Calculations of the initial quantities of mRNA were performed according to the cycle threshold method.
14) The levels of RNA were normalized to b-actin or 18S rRNA quantified via real-time PCR.
Metabolism of Midazolam in K562 Cells K562 cells (2ϫ10 5 cells/ml) were treated with hemin (0 to 50 mM) for 3 d to induce differentiation, and then the medium was exchanged with the medium containing 5 mg/ml midazolam (MDZ). The cells were additionally incubated for 24 h and the culture medium (10 ml) was collected and centrifuged. The supernatant was extracted with 20 ml of hexane and chloroform (7 : 3, v/v), after addition of 20 ml of 2 mg/ml diazepam as internal standard and 5 ml of 0.2 M Na 2 HPO 4 . The extract was centrifuged at 3000ϫg for 10 min at room temperature, and the organic phase (18 ml) was evaporated in vacuo at 43°C to dryness. The dry residue was dissolved in 50 ml solvent A (10 mM ammonium acetate and methanol (50 : 50, v/v) and an aliquot (5 ml) was loaded onto an ODS column (YMC Pac Pro C 18 50 mmϫ2.0 mm i.d., particle size 3 mm, YMC, Tokyo) and eluted isocratically using solvent A at a flow rate of 0.2 ml/min.
15) The amount of 1-hydroxymidazolam (1-OHMDZ), a metabolite of midazolam, was analyzed by an API3200 triple-quadrupole mass spectrometer (Applied Biosystems/MDS Sciex, Concord, ON, Canada) equipped with turbo ion spray ionization (ESI) source. An alyst software Version 1.4.1 was used to control all parameters of LC and MS. The mass spectrometer was operated in positive ion mode. Quantification was performed using multiple reaction monitoring (MRM) mode to study parent→product ion transitions for MDZ (327. Statistics One-way ANOVA followed by Scheffe's test was used for comparisons of values between the control group and hemin treatment groups. All data were analyzed with the statisitical program SPSS for Windows (SPSS, Chicago, IL, U.S.A.). A p-value Ͻ0.05 was considered statistically significant. RESULTS K562 cells were grown in suspension culture and induced to differentiate by treatment with hemin. 16) As shown in Fig.  1 , hemin induces the differentiation of K562 cells in a dosedependent manner and 65% of the cells were benzidine-positive after 3 d culture with 50 mM hemin. Previously we have reported the expression profile of CYP genes in uninduced K562 cells, 7) where we identified a variety of expression levels for the CYP1A1, CYP1B1, CYP2A6, CYP2A7, CYP2D6, CYP2E1, CYP3A4 and CYP3A5 genes. To elucidate the effects of cellular differentiation on the CYP gene expression in K562 cells, we measured the CYP gene expression in the hemin-induced cells by subtype-specific RT-PCR. Among the CYPs analyzed, the expression levels of four family members changed with the differentiation index (Fig.  2) . The expression of CYP1A1 and CYP3A4 increased whereas that of CYP1B1 and CYP2E1 decreased in response to hemin induction. Quantitative evaluation of the changes in the expression of CYP1A1, CYP1B1, CYP2E1 and CYP3A4 using real-time PCR is shown in Fig. 3 . The expression of CYP1A1 and CYP3A4 was elevated 2.5-fold and 3.5-fold, and contrary, that of CYP1B1 and CYP2E1 decreased to 11% and 3% of the control levels, respectively. The induction of CYP3A4 and reduction of CYP2E1 genes appeared within 24 h after hemin-induction of differentiation (data not shown).
To know whether the change in CYP3A4 gene expression is relevant to the metabolism in the differentiated K562 cells, we measured the metabolic activity of midazoram, a typical substrate of CYP3A. 17, 18) As shown in Fig. 4 , the 1-hydroxylation of midazolam, which is mainly catalyzed by CYP3A4, increased by about 2-folds at 50 mM hemin in a hemin dose dependent manner. This increment in the metabolic activity is almost correspondent to that in CYP3A4 gene expression.
It has been well established that transcription factors such as AhR, ARNT, CAR, PXR, RXR and glucocorticoid receptor (GR) are responsible for subtype-specific regulation of CYP gene expression. 19, 20) To further elucidate the involvement of these factors in the hemin-induced changes to the CYP gene expression profile in differentiated K562 cells, we analyzed their expression by RT-PCR. As shown in Fig. 5 , a significant induction of AhR, ARNT, CAR and PXR genes was observed, whereas no RXR or PPARg transcripts were evident and no detectable changes in GR expression in these cells after 3 d of treatment with 50 mM hemin.
DISCUSSION
The human leukemia K562 cell line is a well-established model system for the study of both spontaneous and induced differentiation to erythrocytic, granulocytic and monocytic lineages. 16) To elucidate the role of drug metabolizing enzymes in hematogenesis, and in the etiology of human hematopoietic malignancy and bone marrow chemotherapeutic drug resistance, we analyzed the effects of hemin-induced differentiation on the CYP gene expression in K562 cells. We subsequently found that the expression levels of many CYP genes changed in response to hemin-induced differentiation of K562 cells toward an erythrocyte lineage. In particular, a significant reduction in CYP1B1 and CYP2E1 and large increase in CYP1A1 and CYP3A4 was evident (Figs. 2,  3 ). For CYP3A4, the metabolic activity was also found to mirror the gene expression profile (Fig. 4) .
Although the exact regulatory mechanism underlying these changes in CYP expression is not clear at present, several transcription factors such as GATA-1 and NF-E2 that are known to participate in the hematopoietic cell differentiation might be involved. 21, 22) Furthermore, it has been well established that transcription factors such as AhR, CAR, PXR and RXR are responsible for the subtype-specific regulation of CYP genes. 19 ) Indeed, our current data reveal significant changes in the levels of several of these transcription factors during cell differentiation in K562 cells. We observed the induction of AhR and PXR expression and speculate that this might be related to the up-regulation of CYP1A1 and CYP3A4, respectively. On the contrary, CYP1B1 expression was reduced. This discrepancy between CYP1A1 and CYP1B1 gene expression must be solved in the following study.
Previously we have shown that oxidative stress induces the expression of CYP3A4 in K562 cells. 8) Our present findings show that hemin exerts similar effects upon CYP3A4, but as oxidative stress does not induce cell differentiation, this suggests that different signaling pathways underlie these two stimuli. Further precise analyses should, therefore, be carried out to determine the molecular basis of the differentiationrelated regulation of CYP gene expression. Recent study demonstrated the expression of several CYP genes in the CD34 ϩ hematopoietic stem cells. 23) Together with our data, it is possible that the cells at the early stage of hematopoietic differentiation may be influenced by interaction with xenobiotics, depending on the extents of CYP expresstion.
Although the physiological implications of the alteration in the levels of drug metabolic enzymes during hematopoietic differentiation are still unclear, it is noteworthy that the activities of these enzymes might vary during hematopoietic differentiation. These changes may thus influence the susceptibility of cells to xenobiotics and/or the adverse effects of therapeutic drugs. 3, 24) This variation may also impact upon the metabolism of endogenous substrates, such as steroids and prostaglandins. These changes, therefore, seem likely to be controlled coordinately by interactions between many different transcriptional factors and to play an important role in the maintenance of the normal functions of hematopoietic cells.
